Gary Glick, Odyssey Therapeutics CEO

Af­ter bring­ing his to­tal raise for Odyssey to $386M, Gary Glick is ready to start ink­ing deals. Just watch

If there’s one thing Gary Glick ex­cels at, it’s rais­ing mon­ey for his star­tups. Even in this soured fi­nan­cial en­vi­ron­ment.

No soon­er had he closed his whop­ping big launch round for Odyssey Ther­a­peu­tics — an­nounc­ing it late last year with $218 mil­lion brim­ming in his cof­fers — than he was off and run­ning on the Se­ries B. And to­day he’s tak­ing the wraps off of the added cash — all $168 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.